Menu Search
Equities

Richter Gedeon Vegyeszeti Gyar Nyrt

GEDSF:PKL

Richter Gedeon Vegyeszeti Gyar Nyrt

Actions
  • Price (USD)24.85
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Apr 03 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		RICHTER:BUD since
announced		Transaction
value
BCI Pharma SASDeal completed19 Jun 202419 Jun 2024Deal completed16.46%12.89m
Estetra SADeal completed03 May 202403 May 2024Deal completed17.09%187.69m
Mithra Pharmaceuticals SA-Undisclosed France AssetsDeal completed03 May 202403 May 2024Deal completed17.09%--
Richter-Helm Biologics GmbH & Co KGAnnounced06 Mar 202406 Mar 2024Announced13.13%44.07m
Richter-Helm Biotec GmbH & Co. KGAnnounced06 Mar 202406 Mar 2024Announced13.13%77.94m
Data delayed at least 15 minutes, as of Nov 05 2024 14:33 GMT.

Institutional shareholders

0.10%Per cent of shares held by top holders
HolderShares% Held
Fiera Capital (UK) Ltd.as of 30 Jun 202483.29k0.05%
Vector Asset Management S.A.as of 31 Dec 202360.00k0.03%
State Street Global Advisors France SAas of 31 Dec 202318.18k0.01%
Franklin Templeton Institutional LLCas of 31 Mar 202410.66k0.01%
HSBC Global Asset Management (Hong Kong) Ltd.as of 31 Jul 20225.29k0.00%
First Trust Advisors LPas of 31 Mar 20242.23k0.00%
BlackRock Advisors (UK) Ltd.as of 31 Jul 20231.12k0.00%
Acadian Asset Management LLCas of 31 Mar 2024737.000.00%
Dimensional Fund Advisors Ltd.as of 31 Dec 20230.000.00%
More ▼
Data from 31 Dec 2023 - 30 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.